Evidence map›Paper›PMID 9621037›Full record

ArticleJournal of virology1998

Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells.

R E Sutton, H T Wu, R Rigg, E Böhnlein, P O Brown

Abstract read
In one paragraph

Article in Journal of virology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The effect of lentivirus-mediated TH and GDNF genetic engineering mesenchymal stem cells on Parkinson's disease rat model.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2011
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

R E SuttonDepartment of Biochemistry and Howard Hughes Medical Institute, Stanford University Medical Center, Stanford, California 94305, USA. sutton@cmgm.stanford.edu
H T Wu
R Rigg
E Böhnlein
P O Brown

Funding

CLONING OF THE HTLV-1 CELLULAR RECEPTORK08CA071671 · NCI · STANFORD UNIVERSITY · PI SUTTON, RICHARD E. · 1996 to 1998
–
DEVELOPMENT OF NEW APPROACHES TO INHIBIT GROWTH OF HIVR01AI036898 · NIAID · STANFORD UNIVERSITY · PI BROWN, PATRICK O. · 1994 to 1997
–
NCI NIH HHS CA71671NIAID NIH HHS AI36898
6 · The paper itself

Abstract

Lentiviruses are potentially advantageous compared to oncoretroviruses as gene transfer agents because they can infect nondividing cells. We demonstrate here that human immunodeficiency virus type 1 (HIV-1)-based vectors were highly efficient in transducing purified human hematopoietic stem cells. Transduction rates, measured by marker gene expression or by PCR of the integrated provirus, exceeded 50%, and transduction appeared to be independent of mitosis. Derivatives of HIV-1 were constructed to optimize the vector, and a deletion of most of Vif and Vpr was required to ensure the long-term persistence of transduced cells with relatively stable expression of the marker gene product. These results extend the utility of this lentivirus vector system.

Indexed as

Genetic VectorsGene Transfer TechniquesGene Products, vifGene Products, vprHematopoietic Stem CellsHIV-1Humansvif Gene Products, Human Immunodeficiency VirusVirus Replicationvpr Gene Products, Human Immunodeficiency VirusGene Products, vifGene Products, vprvif Gene Products, Human Immunodeficiency Virusvpr Gene Products, Human Immunodeficiency Virus

Identifiers

PMID9621037
PMCPMC110379

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.